Orthopedic medtech company DePuy Synthes has entered into a definitive agreement to acquire selective rights for Gemtrack, a proprietary tracking technology for shoulder, hip and knee surgeries
The company is aiming to bring the first-to-market radiofrequency miniature tracker technology across joint reconstruction procedures for both navigation and robotic applications, according to a May 26 news release from DePuy Synthes.
The agreement allows DePuy Synthes to develop, manufacture and commercialize Gemtrack across its joint portfolio.
Radiofrequency technology can potentially eliminate the need for infrared cameras and line-of-sight dependence, reduce the reliance on invasive anchors and enable continuous, real-time tracking.
Pending successful product development and regulatory approvals, the technology could create a new standard for integrated image-guided and robotic-assisted joint surgery, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
